Sunesis Pharmaceuticals Inc (SNSS.OQ)
23 Mar 2018
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|2009||Non-Executive Independent Chairman of the Board|
|44||2018||Interim Chief Executive Officer, Director|
|2017||Chief Financial Officer, Senior Vice President - Finance and Corporate Development|
|51||2012||Executive Vice President - Development, Chief Medical Officer|
- BRIEF-Sunesis Pharmaceuticals Announces Cancellation Of Presentation And Webcast At Cowen & Company 38Th Annual Health Care Conference
- BRIEF-Sunesis Pharma Qtrly Loss Per Share $0.21
- BRIEF-Boxer Capital Llc Reports 6.2 Percent Passive Stake In Sunesis Pharmaceuticals Inc
- BRIEF-Sunesis Pharmaceuticals Inc - Daniel Swisher Resigns As CEO Effective End Of 2017
- BRIEF-Sunesis Pharmaceuticals Appoints William Quinn As CFO